Eris Lifesciences LtdNSE: ERIS

Press Release Nov 08 2023

· Issued by Eris Lifesciences Ltd

Filed with NSE ·

Eris Lifesciences Limited has informed the Exchange regarding a press release dated November 08, 2023, titled "Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India".

View Attachment

6ix hasn’t read this filing yet.

Eris Lifesciences Ltd on 6ix

In the deck

Later from Eris Lifesciences

All Eris Lifesciences news releases